Related Experiment Video
Updated: Nov 3, 2025

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Τhe association of heart failure across left ventricular ejection fraction with mortality in atrial fibrillation
Anastasios Kartas1, Athanasios Samaras1, Evangelos Akrivos2
1First Department of Cardiology, AHEPA University Hospital, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, 54124, Greece.
Insights
Heart failure (HF) significantly increases mortality risk in patients with atrial fibrillation (AF), regardless of ejection fraction. The risk of death escalates sharply when left ventricular ejection fraction falls below 25%.
Area of Science:
- Cardiology
- Internal Medicine
- Clinical Research
Background:
- Atrial fibrillation (AF) is a common arrhythmia often coexisting with heart failure (HF).
- The prognostic impact of HF across the spectrum of left ventricular ejection fraction (LVEF) in AF patients requires further clarification.
Purpose of the Study:
- To investigate the prognostic significance of heart failure (HF) in patients with comorbid atrial fibrillation (AF).
- To examine how HF impacts mortality risk across different ranges of left ventricular ejection fraction (LVEF).
Main Methods:
- Retrospective cohort study of 1063 patients diagnosed with AF.
- Analysis using Cox proportional-hazards and spline models to assess mortality risk.
- Evaluation of HF presence and LVEF categories (reduced, mid-range, preserved) as predictors of all-cause mortality.
Main Results:
- Heart failure (HF) was present in 52.9% of patients at baseline.
- The presence of HF was associated with a significantly higher risk of all-cause mortality (aHR 2.17).
- This increased mortality risk was consistent across HF with reduced, mid-range, and preserved LVEF.
- A steep increase in mortality risk was observed as LVEF dropped below 25% in patients with HF.
Conclusions:
- Heart failure (HF) is an independent predictor of mortality in patients with atrial fibrillation (AF).
- The adverse prognostic impact of HF persists across all LVEF categories in AF patients.
- A critically low LVEF (<25%) in AF patients with HF portends a particularly high risk of death.
Aims:
The aim of this study is to investigate the prognostic implications of the presence of heart failure (HF) across the range of left ventricular ejection fraction (LVEF) in patients with comorbid atrial fibrillation (AF).
Methods And Results:
We conducted a retrospective cohort study of 1063 patients (median age 76 years), discharged from the cardiology ward with a primary or secondary diagnosis of AF between 2015 and 2018. We used Cox proportional-hazards and spline models to examine the association of the presence of HF, across the range of LVEF, with the primary outcome of all-cause mortality. HF was documented in 52.9% of patients at baseline. During a median follow-up of 31 months (interquartile range 10 to 52 months), 37.3% of patients died. The presence of HF was associated with a significantly higher risk of mortality [adjusted hazard ratio (aHR) 2.17; 95% confidence interval (CI), 1.70 to 2.77; P < 0.001], which was evident across HF with reduced (aHR 3.03; 95% CI 2.41 to 4.52), mid-range (aHR 2.08; 95% CI 1.47 to 2.94), and preserved LVEF (aHR 1.94; 95% CI 1.47 to 2.55). Among patients with HF, the spline curve depicted a non-linear association between LVEF and the risk of death, in which there was a steep and progressive increase in mortality for every 5% reduction in LVEF below 25% (aHR 1.97, 95% CI 1.04 to 3.73, P = 0.04).
Conclusions:
In patients with AF who were discharged from the hospital, the presence of HF at baseline was independently associated with a twofold risk of death, which was significant across LVEF-classified HF subtypes. Among patients with AF and HF, the risk of death rose significantly as LVEF was reduced below 25%.
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure II: Pathophysiology
Heart Failure I: Introduction
Heart Failure III: Clinical Manifestations
Heart Failure V: Medical Management

